Over the latest trailing 12-month period, total return cagr is -4.44%. The comparable SPY value is +22.80%. Year-to-date total return is -4.57%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Total Return CAGR averages -36.41% over 3 years and -46.28% over 5 years; the trailing 12 months came in at -4.44%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
Teladoc Health, Inc. (TDOC)
Total Return growth vs the same quarter one year earlier, last 40 quarters.
Quarter-end value of $100 invested at the start of the available history, with dividends reinvested; the newest quarter may be quarter-to-date.
Reported annual fiscal-period values; no daily interpolation.
| Year | Total return for the year |
|---|---|
| 2026 (YTD) | -4.57% |
| 2025 | -22.99% |
| 2024 | -57.82% |
| 2023 | -8.88% |
| 2022 | -74.24% |
| 2021 | -54.08% |
| 2020 | +138.84% |
| 2019 | +68.89% |
| 2018 | +42.24% |
| 2017 | +111.21% |
| 2016 | -8.13% |
| Quarter | QoQ | YoY |
|---|---|---|
| Q3 2026 (QTD) | -20.4% | -18.5% |
| Q2 2026 | +53.9% | -3.7% |
| Q1 2026 | -21.4% | -32.6% |
| Q4 2025 | -15.5% | -25.6% |
| Q3 2025 | -5.9% | -10.7% |
| Q2 2025 | +7.7% | -14.2% |
| Q1 2025 | -13.1% | -46.2% |
| Q4 2024 | +1.4% | -57.9% |
| Q3 2024 | -9.6% | -50.5% |
| Q2 2024 | -32.6% | -59.8% |
| Q1 2024 | -31.9% | -39.9% |
| Q4 2023 | +19.3% | -6.6% |
| Q3 2023 | -26.6% | -26.9% |
| Q2 2023 | +0.9% | -28.0% |
| Q1 2023 | +5.8% | -65.3% |
| Q4 2022 | -6.7% | -74.9% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier. The newest quarter is in progress (quarter-to-date).
